Cargando…
Dystroglycanopathy: From Elucidation of Molecular and Pathological Mechanisms to Development of Treatment Methods
Dystroglycanopathy is a collective term referring to muscular dystrophies with abnormal glycosylation of dystroglycan. At least 18 causative genes of dystroglycanopathy have been identified, and its clinical symptoms are diverse, ranging from severe congenital to adult-onset limb-girdle types. Moreo...
Autor principal: | Kanagawa, Motoi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8658603/ https://www.ncbi.nlm.nih.gov/pubmed/34884967 http://dx.doi.org/10.3390/ijms222313162 |
Ejemplares similares
-
Muscular Dystrophy with Ribitol-Phosphate Deficiency: A Novel Post-Translational Mechanism in Dystroglycanopathy
por: Kanagawa, Motoi, et al.
Publicado: (2017) -
Contribution of Dysferlin Deficiency to Skeletal Muscle Pathology in Asymptomatic and Severe Dystroglycanopathy Models: Generation of a New Model for Fukuyama Congenital Muscular Dystrophy
por: Kanagawa, Motoi, et al.
Publicado: (2014) -
A molecular overview of the primary dystroglycanopathies
por: Brancaccio, Andrea
Publicado: (2019) -
Residual laminin-binding activity and enhanced dystroglycan glycosylation by LARGE in novel model mice to dystroglycanopathy
por: Kanagawa, Motoi, et al.
Publicado: (2009) -
Prenatal muscle development in a mouse model for the secondary dystroglycanopathies
por: Kim, Jihee, et al.
Publicado: (2016)